ZyVersa Therapeutics Inc. (ZVSA)

NASDAQ HEALTHCARE
$0.20 -0.10% RSI 40 Neutral Add Alert

Moving Averages

SMA 200
$0.18
Price above

Company Profile

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. The company is headquartered in Weston, Florida.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$1.54M
P/E Ratio
None
EPS
$-4.18
Beta
0.791
Dividend Yield
0.00%
52-Week High
$0.8
52-Week Low
$0.11

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 44.0
VRTX
Vertex Pharmaceuticals Inc
RSI 50.0
CRSP
CRISPR Therapeutics AG
RSI 55.0
MRNA
Moderna Inc
RSI 44.0
VKTX
Viking Therapeutics Inc
RSI 57.0
SRPT
Sarepta Therapeutics Inc
RSI 44.0
EDIT
Editas Medicine Inc
RSI 59.0
IOVA
Iovance Biotherapeutics Inc
RSI 54.0
NVAX
Novavax Inc
RSI 65.0
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 61.0

Data last updated: May 13, 2026 at 7:11 AM EDT

Track ZVSA for free

Get e-mail RSI alerts when ZyVersa Therapeutics Inc. enters oversold or overbought territory. Free forever.

Add Alert